Adult liver transplantation at UCL: update 2002.
The authors present the results of a single centre study of 587 liver transplants performed in 522 adults during the period 1984-2002. Results have improved significantly over time due to better pre-, peri- and post-transplant care. One, five, ten and fifteen year actuarial survivals for the whole patient group are 81.2; 69.8; 58.9 and 51.2%. The high incidence of de novo tumors (12.3%), of cardiovascular diseases (7.5%) and of end-stage renal function (3.6%) should be further incentives to tailor the immunosuppression to the individual patient and to direct the attention of the transplant physician to the long-term quality of life of the liver recipient.
Liver Transplant Program, Cliniques Universitaires Saint-Luc, Université catholique de Louvain, 1200 Brussels, Belgium. Lerut@chir.ucl.ac.be
J
J
Lerut
J
J
Matthys
J
J
Lemaire
V
V
Van Thuyne
O
O
Ciccarelli
P
P
Goffette
A
A
Peeters
S
S
Aunac
M
M
Boddeus
M A
MA
Carlier
E
E
Danse
M
M
De Kock
Ch
Ch
De Reyck
M
M
Donataccio
A
A
Geubel
D
D
Gonze
P
P
Goubau
D
D
Latinne
P F
PF
Laterre
A
A
Luts
G
G
Cool
J B
JB
Otte
Y
Y
Horsmans
J
J
Martinez
G
G
Orlando
J
J
Rahier
R
R
Reding
M
M
Reynaert
P
P
Starkel
Ch
Ch
Sempoux
St
S
Talpe
L
L
Van Obbergh
F
F
Veyckemans
P
P
Wallemacq
X
X
Wittebolle
F
F
Roggen
D000328:Adult; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016031:Liver Transplantation; D016019:Survival Analysis; D016896:Treatment Outcome
D007166:Immunosuppressive Agents